Literature DB >> 20495983

Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy.

Stéphane Vignes1, Raphaël Porcher, Maria Arrault, Alain Dupuy.   

Abstract

BACKGROUND: Lymphedema treatment is based on an intensive decongestive physiotherapy phase of volume reduction followed by a long-term maintenance phase. Factors influencing the morbid lymphedema volume increase during maintenance were analyzed.
MATERIALS AND METHODS: Among 867 consecutive women recruited and followed in a single lymphology unit, 682 were analyzed. The other 185 were not analyzed because of an initial lymphedema volume <250 ml, <20% lymphedema volume decrease during the intensive phase, or they were lost to follow-up. Lymphedema volume was recorded prior to and at the end of intensive phase, and at each follow-up visit. During follow-up, treatment failure was defined as a lymphedema volume increase of ≥50% of the total reduction obtained during the intensive phase.
RESULTS: Median lymphedema volume was 936 ml before and 335 ml after intensive decongestive physiotherapy (P < 0.0001). Median follow-up was 28 months. During the maintenance phase, the risk of treatment failure at 1, 2, and 4 years was estimated to be 38.1%, 53.1%, and 64.8%, respectively. Wearing an elastic sleeve during the day and an overnight multilayer low-stretch bandage (median, four nights per week; interquartile range, 2-6) significantly decreased the risk of treatment failure [hazard ratio, 0.53, (0.34-0.82), P = 0.004], whereas manual lymph drainage adjunction to those therapeutic components did not. The risk of treatment failure was also associated with weight and body mass index at inclusion.
CONCLUSION: Risk of maintenance-therapy failure after intensive decongestive physiotherapy was associated with patients characteristics (younger age, higher weight, and body mass index), while elastic sleeve and bandage were associated with better maintenance results. Paradoxical effect of manual lymph drainage is likely to be related to indication bias.

Entities:  

Mesh:

Year:  2010        PMID: 20495983     DOI: 10.1007/s00520-010-0906-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  17 in total

1.  Why and how post-mastectomy edema should be quantified in patients with breast cancer.

Authors:  Christophe Galland; Jean François Auvert; Antoine Flahault; Michel Vayssairat
Journal:  Breast Cancer Res Treat       Date:  2002-09       Impact factor: 4.872

2.  Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema.

Authors:  A Szuba; J P Cooke; S Yousuf; S G Rockson
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

3.  Effective treatment of lymphedema of the extremities.

Authors:  D S Ko; R Lerner; G Klose; A B Cosimi
Journal:  Arch Surg       Date:  1998-04

4.  Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy.

Authors:  Stéphane Vignes; Raphaël Porcher; Maria Arrault; Alain Dupuy
Journal:  Breast Cancer Res Treat       Date:  2006-07-07       Impact factor: 4.872

Review 5.  Risk factors of arm lymphedema in breast cancer patients.

Authors:  Z Kocak; J Overgaard
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

6.  Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema.

Authors:  S R Harris; M R Hugi; I A Olivotto; M Levine
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

7.  Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.

Authors:  Anthony Lucci; Linda Mackie McCall; Peter D Beitsch; Patrick W Whitworth; Douglas S Reintgen; Peter W Blumencranz; A Marilyn Leitch; Sukumal Saha; Kelly K Hunt; Armando E Giuliano
Journal:  J Clin Oncol       Date:  2007-05-07       Impact factor: 44.544

8.  Factors associated with increased breast cancer-related lymphedema volume.

Authors:  Stephane Vignes; Maria Arrault; Alain Dupuy
Journal:  Acta Oncol       Date:  2007       Impact factor: 4.089

9.  Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.

Authors:  Sarah A McLaughlin; Mary J Wright; Katherine T Morris; Gladys L Giron; Michelle R Sampson; Julia P Brockway; Karen E Hurley; Elyn R Riedel; Kimberly J Van Zee
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

Review 10.  Lymphedema management.

Authors:  Andrea L Cheville; Charles L McGarvey; Jeanne A Petrek; Sandra A Russo; Marie E Taylor; Saskia R J Thiadens
Journal:  Semin Radiat Oncol       Date:  2003-07       Impact factor: 5.934

View more
  16 in total

1.  Clinician's Commentary on Canestraro et al.(1.).

Authors:  Margaret McNeely
Journal:  Physiother Can       Date:  2013       Impact factor: 1.037

2.  Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema.

Authors:  Justin C Brown; Andrea L Cheville; Julia C Tchou; Susan R Harris; Kathryn H Schmitz
Journal:  Support Care Cancer       Date:  2013-09-07       Impact factor: 3.603

3.  Use of compression garments by women with lymphoedema secondary to breast cancer treatment.

Authors:  E Longhurst; E S Dylke; S L Kilbreath
Journal:  Support Care Cancer       Date:  2018-02-19       Impact factor: 3.603

Review 4.  Lymphedema following treatment for breast cancer: a new approach to an old problem.

Authors:  Jean O'Toole; Lauren S Jammallo; Melissa N Skolny; Cynthia L Miller; Krista Elliott; Michelle C Specht; Alphonse G Taghian
Journal:  Crit Rev Oncol Hematol       Date:  2013-06-16       Impact factor: 6.312

5.  Association between lymphedema self-care adherence and lymphedema outcomes among women with breast cancer-related lymphedema.

Authors:  Justin C Brown; Anagha Kumar; Andrea L Cheville; Julia C Tchou; Andrea B Troxel; Susan R Harris; Kathryn H Schmitz
Journal:  Am J Phys Med Rehabil       Date:  2015-04       Impact factor: 2.159

Review 6.  Nonoperative Treatment of Lymphedema.

Authors:  Mark V Schaverien; Julie A Moeller; Sarah D Cleveland
Journal:  Semin Plast Surg       Date:  2018-04-09       Impact factor: 2.314

7.  Role of physiotherapy and patient education in lymphedema control following breast cancer surgery.

Authors:  Shiang-Ru Lu; Rong-Bin Hong; Willy Chou; Pei-Chi Hsiao
Journal:  Ther Clin Risk Manag       Date:  2015-02-25       Impact factor: 2.423

8.  Are compression corsets beneficial for the treatment of breast cancer-related lymphedema? New opportunities in physiotherapy treatment - a preliminary report.

Authors:  Rita Hansdorfer-Korzon; Jacek Teodorczyk; Agnieszka Gruszecka; Piotr Lass
Journal:  Onco Targets Ther       Date:  2016-04-07       Impact factor: 4.147

Review 9.  Effects of manual lymphatic drainage on breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Tsai-Wei Huang; Sung-Hui Tseng; Chia-Chin Lin; Chyi-Huey Bai; Ching-Shyang Chen; Chin-Sheng Hung; Chih-Hsiung Wu; Ka-Wai Tam
Journal:  World J Surg Oncol       Date:  2013-01-24       Impact factor: 2.754

10.  Long-term effects of complex decongestive therapy in breast cancer patients with arm lymphedema after axillary dissection.

Authors:  Jung Min Hwang; Ji Hye Hwang; Tae Won Kim; Seung Yeol Lee; Hyun Ju Chang; In Ho Chu
Journal:  Ann Rehabil Med       Date:  2013-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.